Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

British Journal of Cancer

Volumn 102, Issue 7, 2010, Pages 1123-1128

  Northover, J ^a   Glynne Jones, R ^b   Sebag Montefiore, D ^c   James, R ^d   Meadows, H ^e   Wan, S ^e   Jitlal, M ^e   Ledermann, J ^e  

^a ST MARK S HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d MAIDSTONE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anal cancer; Chemoradiation; Long term follow up

Indexed keywords

FLUOROURACIL; IRIDIUM; MITOMYCIN C;

ADULT; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CONTROLLED STUDY; EPIDERMOID ANAL CANCER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT DURATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MITOMYCIN; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS;

EID: 77950347260     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605605     Document Type: Article

References (17)

1. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson III AB, Thomas Jr CR, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299: 1914-1921
2. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15: 2040-2049
3. Cancer Research UK (2008) Risks and causes of anal cancer. http:// www.cancerhelp.org.uk/type/anal-cancer/about/risks-and-causes-of-anal-cancer. Accessed on 19 June, 2009. Ref Type: Electronic Citation
4. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR, for the Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36-46
5. Daher IN, Yeh ET (2008) Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med 5: 797-805
6. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101: 270-280
7. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14: 2527-2539
8. Frisch M, Glimelius B, Wohlfahrt J, Adami HO, Melbye M (1999) Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst 91: 708-715
9. James R, Wan S, Glynne-Jones R, Sebag-Montefiore D, Kadalayil L, Northover J, Cunningham D, Meadows H, Ledermann J, on behalf of the II ACT study group (2009) A randomised trial of chemoradiation using combination 5FU/mitomycin or 5FU/cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol 27 suppl: 797s (abstr LBA4009)
10. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249
11. Myerson RJ, Shapiro SJ, Lacey D, Lopez M, Birnbaum E, Fleshman J, Fry R, Kodner I (1995) Carcinoma of the anal canal. Am J Clin Oncol 18: 32-39
12. Schwager K, Nebel A, Baier G, Hoppe F (2000) Second primary carcinomas in the upper aerodigestive tract in different locations and age groups. Laryngorhinootologie 79: 599-603
13. Spiessl B, Hermanek P, Scheibe O, Wagner G (eds) (1985) UICC TNM-Atlas Illustrated Guide to the TNM/pTNM-Classification of Malignant Tumours 2nd edn, Springer-Verlag: Berlin
14. Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91: 4-15
15. UKCCCR Anal Cancer Trial Working Party (1996) Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348: 1049-1054
16. Viale PH, Yamamoto DS (2008) Cardiovascular toxicity associated with cancer treatment. Clin J Oncol Nurs 12: 627-638
17. Zakotnik B, Budihna M, Smid L, Soba E, Strojan P, Fajdiga I, Zargi M, Oblak I, Lesnicar H (2007) Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin. Int J Radiat Oncol Biol Phys 67: 685-690